tiprankstipranks
Trending News
More News >
BeiGene Ltd (HK:6160)
:6160
Hong Kong Market
Advertisement

BeiGene Ltd (6160) Similar Stocks

Compare
21 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BeiGene Ltd
HK$184.20
HK$297.41B
57.57%
2 Buy
0 Hold
0 Sell
Moderate Buy
Innovent Biologics
$12.28
$21.27B
128.80
123.18%
7 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
$4.40
$17.33B
30.75
218.84%
7 Buy
2 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$107.90
HK$323.88B
21.29
221.71%
3 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$36.02
HK$218.11B
41.15
83.12%
6 Buy
1 Hold
0 Sell
Strong Buy
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$76.20
HK$478.57B
65.56
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6160
BeiGene Ltd
184.20
69.90
61.15%
IVBXF
Innovent Biologics
12.28
6.99
132.14%
WXIBF
Wuxi Biologics (Cayman)
4.40
2.99
212.06%
HK:2359
WuXi AppTec Co., Ltd. Class H
107.90
75.58
233.85%
HK:3692
Hansoh Pharmaceutical Group Company Limited
36.02
16.33
82.94%
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
76.20
22.50
41.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis